Latest Low-density lipoprotein Stories
Analysis From Prespecified Exploratory Endpoints Presented in Late-Breaking Session at ACC.15 Showed Repatha Plus Standard of Care Lowered Cardiovascular Events THOUSAND OAKS, Calif., March
Data From PCSK9 Inhibitor Study Support Regulatory Filing in Japan THOUSAND OAKS, Calif., March 14, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase
Emerald Logic FACET software generates predictive models and identifies novel variables driving RVX-208 drug efficacy, safety and reduced MACE incidence TSX Exchange Symbol: RVX
Data Evaluating the Effect of Repatha(TM)(Evolocumab) on LDL-C and Cardiovascular Events to be Featured in Late-Breaking Session THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)
Congressional briefing highlights results of national patient research indicating the need to improve medication adherence, access to medication and enrollment of women in clinical trials, policy recommendations
Proper cholesterol management can make the difference between a full active lifestyle and one plagued with avoidable health problems.
View the Interactive Maps on www.CholesterolCounts.com for a Snapshot of Cholesterol Awareness Across the U.S. BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb.
PCSK9 inhibitors could cost the health care system as much as $150 billion annually WOONSOCKET, R.I., Feb.
Lipitor Lawsuit Pretrial Proceedings Are Underway On Behalf Of Men And Women Across The Country Who Contend The Cholesterol-Lowering Statin Drug Carries A Risk Of Type 2 Diabetes Columbus,
- A woman chauffeur.
- A woman who operates an automobile.